Subsequent cancer | Initial primary breast cancer | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Age range, years | Location | Final assessment | Type of surgery | Initial surgery intervala | Pathology | Size, mm | TNM | ER | PR | HER2 | Pathology | Size, mm | TNM | ER | PR | HER2 |
35–40 | contralateral breast | BI-RADS 3 | Mastectomy | 60.0 | IDC | 9 | T1bN0M0 | pos | pos | neg | IDC | 30 | T2N1M0 | neg | neg | neg |
50–55 | contralateral breast | BI-RADS 4 | BCS | 56.3 | DCIS | 15 | TisN0M0 | pos | pos | neg | DCIS | 15 | TisN0M0 | pos | pos | neg |
45–50 | contralateral breast | BI-RADS 4 | BCS | 24.7 | Mucinous carcinoma | 7 | T1bN0M0 | pos | pos | neg | DCIS with microinvasion | 1 | T1miN0M0 | pos | pos | neg |
40–45 | contralateral breast | BI-RADS 4 | BCS | 38.7 | ILC | 11 | T1cN0M0 | pos | pos | neg | IDC | 26 | T2N0M0 | pos | pos | neg |
70–75 | sternum | Suspicious for malignancy | BCS | 81.5 | N/A | – | – | – | – | – | IDC | 23 | T2N0M0 | pos | neg | neg |
60–65 | mediastinum | Suspicious for malignancy | BCS | 60.4 | Metastatic carcinoma | – | – | pos | neg | neg | ILC | 26 | T2N0M0 | pos | neg | neg |
45–50 | chest wall | Suspicious for malignancy | Mastectomy | 60.4 | Metastatic carcinoma | – | – | pos | neg | neg | IDC | 10 | T1bN0M0 | pos | pos | neg |